Literature DB >> 12184164

Angiogenesis in advanced colorectal adenocarcinoma with special reference to tumoral invasion.

Cláudio Tarta1, Cláudio Rolim Teixeira, Shinji Tanaka, Ken Haruma, César Chiele-Neto, Vinícius Duval da Silva.   

Abstract

BACKGROUND: Angiogenesis is a crucial step in tumor growth and progression. Its quantification by microvessel counting has a prognostic value in several types of malignancies and recently has been appraised in gastrointestinal tumors. AIM: To assess the prognostic significance of microvessel quantification in colorectal carcinomas, studying its association with hematogenous metastases, survival and clinicopathological variables such as size, histologic differentiation and depth of tumoral invasion. PATIENTS/
METHODS: Forty eight patients with colorectal adenocarcinoma were included in this study. Histologic sections of invasion tumoral margin (4 microns) were analyzed and endothelined microvessels were immunostained with monoclonal mouse Von Willebrand Factor (anti-FVIII). The microvessel count was performed from the identification of the area with increased microvessel density--hot spots--and results of the mean in five of these fields.
RESULTS: The cut-off microvessel count was 14 microvessels/0.785 mm2, which divided the sample into hypovascular and hypervascular groups. While 2/8 (25%) tumors with muscularis propria invasion were classified as hypervascular, 11/15 (73%) tumors with serosa or perivisceral fat were classified as hypervascular. However, a non-significant statistical association was found between the angiogenesis quantification, hematogenous metastases, survival and clinicopathological variables such as size and histologic differentiation of the tumor.
CONCLUSIONS: The findings of significantly increase of microvessel count in conformity with tumoral invasion depth supports the hypothesis that tumor progression might be related to angiogenesis. Although angiogenesis is an important step in the tumoral growth and during the metastatization process, other factors can be implicated.

Entities:  

Mesh:

Year:  2002        PMID: 12184164     DOI: 10.1590/s0004-28032002000100007

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  7 in total

1.  The clinical value of von Willebrand factor in colorectal carcinomas.

Authors:  Vera S Schellerer; Larissa Mueller-Bergh; Susanne Merkel; Robert Zimmermann; Dominik Weiss; Anne Schlabrakowski; Elisabeth Naschberger; Michael Stürzl; Werner Hohenberger; Roland S Croner
Journal:  Am J Transl Res       Date:  2011-09-23       Impact factor: 4.060

2.  Expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic adenocarcinoma: correlation with microvessel density.

Authors:  Hans-U Kasper; Hella Wolf; Uta Drebber; Helmut-K Wolf; Michael-A Kern
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

Review 3.  Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas.

Authors:  Xiao-Feng Sun; Hong Zhang
Journal:  Mol Cancer       Date:  2006-10-06       Impact factor: 27.401

Review 4.  Can vascular endothelial growth factor and microvessel density be used as prognostic biomarkers for colorectal cancer? A systematic review and meta-analysis.

Authors:  Yibaina Wang; Xiaoping Yao; Jie Ge; Fulan Hu; Yashuang Zhao
Journal:  ScientificWorldJournal       Date:  2014-03-27

5.  Tumor-Associated Macrophage (TAM) and Angiogenesis in Human Colon Carcinoma.

Authors:  Manal A Badawi; Dalia M Abouelfadl; Sonia L El-Sharkawy; Wafaa E Abd El-Aal; Naglaa F Abbas
Journal:  Open Access Maced J Med Sci       Date:  2015-04-27

6.  Predictive Factors of Positive Circumferential and Longitudinal Margins in Early T3 Colorectal Cancer Resection.

Authors:  M Ashraf Balbaa; Noha Elkady; Emad M Abdelrahman
Journal:  Int J Surg Oncol       Date:  2020-06-27

Review 7.  The measurement and modification of hypoxia in colorectal cancer: overlooked but not forgotten.

Authors:  Teddy Fletcher; Alex J Thompson; Hutan Ashrafian; Ara Darzi
Journal:  Gastroenterol Rep (Oxf)       Date:  2022-08-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.